2026 Global: Antimicrobial Susceptibility Testing Market-Competitive Review (2032) report
Description
The 2026 Global: Antimicrobial Susceptibility Testing Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for antimicrobial susceptibility testing market by geography and historical trend. The scope of the report extends to sizing of the antimicrobial susceptibility testing market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
bioMérieux, Becton Dickinson (BD), Thermo Fisher Scientific, Danaher, Bio‑Rad Laboratories, Bruker, Roche Diagnostics, Accelerate Diagnostics, HiMedia Laboratories, and Alifax are widely recognized as ten major companies shaping the antimicrobial susceptibility testing (AST) market, each contributing distinct product portfolios and geographic reach. bioMérieux is known for automated phenotypic systems such as VITEK and rapid AST innovations that target clinical microbiology laboratories and hospital networks. Becton Dickinson offers platforms like BD Phoenix alongside integrated identification workflows and has broad laboratory and hospital penetration globally. Thermo Fisher Scientific supplies a range of AST products including Sensititre plates and automated instruments geared toward high-throughput clinical and research settings, supported by its large global distribution and service network. Danaher participates through subsidiaries (for example Beckman Coulter and Cepheid), delivering automated susceptibility systems and molecular diagnostics that emphasize workflow integration and throughput for diagnostic laboratories.
Bio‑Rad Laboratories and Bruker provide specialized AST-related offerings that complement identification technologies: Bio‑Rad with susceptibility reagents and screening products used in clinical and surveillance contexts, and Bruker with MALDI‑TOF platforms and associated workflows that accelerate identification and feed into susceptibility decision-making. Roche Diagnostics brings established clinical diagnostics scale and regulatory experience to AST markets through integrated platforms and laboratory automation compatible with large hospital systems. Accelerate Diagnostics focuses on rapid phenotypic AST technologies that shorten time‑to‑result in bloodstream infections and other acute-care uses, positioning itself in the rapid‑turnaround segment alongside newer technology entrants. HiMedia Laboratories is a major supplier of culture media, discs, and reagents used globally in routine susceptibility testing and reference laboratories, serving both clinical and industrial microbiology needs. Alifax develops compact automated AST and rapid screening systems targeting decentralized labs and point‑of‑care settings, emphasizing accessibility and reduced hands‑on time.
Together these ten companies span the market’s main segments—automated phenotypic AST, rapid phenotypic platforms, molecular/genotypic resistance assays, consumables (media, discs, MIC plates), and integration with identification systems—driving product differentiation through speed, automation, throughput, and regulatory approvals. Market reports and industry analyses repeatedly list these firms among leading vendors due to their product breadth, global sales channels, R&D investment, and strategic partnerships that expand AST capabilities into surveillance, hospital stewardship, and pharmaceutical research applications.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for antimicrobial susceptibility testing market by geography and historical trend. The scope of the report extends to sizing of the antimicrobial susceptibility testing market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
bioMérieux, Becton Dickinson (BD), Thermo Fisher Scientific, Danaher, Bio‑Rad Laboratories, Bruker, Roche Diagnostics, Accelerate Diagnostics, HiMedia Laboratories, and Alifax are widely recognized as ten major companies shaping the antimicrobial susceptibility testing (AST) market, each contributing distinct product portfolios and geographic reach. bioMérieux is known for automated phenotypic systems such as VITEK and rapid AST innovations that target clinical microbiology laboratories and hospital networks. Becton Dickinson offers platforms like BD Phoenix alongside integrated identification workflows and has broad laboratory and hospital penetration globally. Thermo Fisher Scientific supplies a range of AST products including Sensititre plates and automated instruments geared toward high-throughput clinical and research settings, supported by its large global distribution and service network. Danaher participates through subsidiaries (for example Beckman Coulter and Cepheid), delivering automated susceptibility systems and molecular diagnostics that emphasize workflow integration and throughput for diagnostic laboratories.
Bio‑Rad Laboratories and Bruker provide specialized AST-related offerings that complement identification technologies: Bio‑Rad with susceptibility reagents and screening products used in clinical and surveillance contexts, and Bruker with MALDI‑TOF platforms and associated workflows that accelerate identification and feed into susceptibility decision-making. Roche Diagnostics brings established clinical diagnostics scale and regulatory experience to AST markets through integrated platforms and laboratory automation compatible with large hospital systems. Accelerate Diagnostics focuses on rapid phenotypic AST technologies that shorten time‑to‑result in bloodstream infections and other acute-care uses, positioning itself in the rapid‑turnaround segment alongside newer technology entrants. HiMedia Laboratories is a major supplier of culture media, discs, and reagents used globally in routine susceptibility testing and reference laboratories, serving both clinical and industrial microbiology needs. Alifax develops compact automated AST and rapid screening systems targeting decentralized labs and point‑of‑care settings, emphasizing accessibility and reduced hands‑on time.
Together these ten companies span the market’s main segments—automated phenotypic AST, rapid phenotypic platforms, molecular/genotypic resistance assays, consumables (media, discs, MIC plates), and integration with identification systems—driving product differentiation through speed, automation, throughput, and regulatory approvals. Market reports and industry analyses repeatedly list these firms among leading vendors due to their product breadth, global sales channels, R&D investment, and strategic partnerships that expand AST capabilities into surveillance, hospital stewardship, and pharmaceutical research applications.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
